Course opens: 
05/01/2019

Virtual Seminar – January 13-14, 2024 | The Science of Pharmaceutical Compounding: Non-sterile Training

January 13, 2024 to January 14, 2024

Course Format

Home Study (24 hours) pre-read that reviews fundamental concepts in non-sterile compounding to prepare you for the live event. To review the full activity description for the Home Study click here.

2-day Live Virtual Seminar (12 hours) that allows you to connect and interact online, in real time, through open mic Q&A sessions, group discussions, polls, and online chats.

Instructional Design

The Virtual Seminar is a highly interactive Application-based program that strikes a careful balance between a patient-centric and business-centric approach for the learner. Facilitators complement the program by bringing a wealth of personal and professional expertise to the learner’s experience in these two approaches. The program concludes with a learning assessment, which provides feedback to the learner.

Course Description

The seminar, which covers non-hazardous and hazardous drug compounding, is divided into four subsections:

  • Business Basics highlights the importance for a compounding practice to build a unique identity and deliver consistent marketing messages. Participants will construct, assess, rehearse, and deliver marketing messages through written and verbal communication. Business Basics also explores financial management as the participant reviews start-up costs, acquisition costs and expenditures, selling prices, forecasted growth and expectations, and revenue stream generators. A two-year financial plan spreadsheet identifies cornerstones and milestones for the new and expanding compounding practice.
  • Creating a Culture of Quality features implementation methods for regulatory guidelines, standards of practice, and standard operating procedures. Participants will learn how to establish a comprehensive action plan and documentation practices related to all aspects of a compounding practice.
  • Compounding Calculations provides the participant the opportunity to learn and practice common pharmacy calculations, including, interpreting drug monographs, drug conversions, drug strength adjustments applying the certificate of analysis, capsule calculations, displacement calculations, stock concentrates and aliquots for powder blends and powder-in-liquid mixtures, among more.
  • Scientific Principles teaches the participant how to ensure dosage form stability and suitability for the patient. The participant will learn to compound a medication by modifying its route of delivery and/or delivery system while optimizing drug bioavailability, patient safety and positive therapeutic outcomes. Scientific Principles also provides the participant the opportunity to apply a number of core concepts by assessing a series of clinical cases. It concludes with a comprehensive method for prescription assessment and clinical decision-making, both critical to a successful compounding practice.

 

Intended audience

 

  • Pharmacists, Pharmacy Technicians, Pharmacy Managers, Designated persons in positions of responsibility, and Quality Assurance & Quality Control officers looking to advance their practical non-sterile compounding skills related to any professional setting.
  • Auditors / Inspectors looking to hone their assessment skills in concert with the standards described and detailed in this Activity.

 


Learning Objectives

Pharmacists

  1. Assess, write and construct marketing messages and material.
  2. Practice delivering a unique marketing message through verbal communication.
  3. Evaluate a two-year financial spreadsheet for a non-hazardous and hazardous compounding practice.
  4. Assess acquisition costs and establish the selling price of compounded medications.
  5. Summarize regulatory guidelines and standards of practice for compounding.
  6. Demonstrate how to customize standard operating procedures.
  7. Compare standards of practice for non-hazardous to hazardous drug compounding.
  8. Design a collaborative compounding practice.
  9. Relate standards of practice and workflow dynamics to facility design models.
  10. Relate standard operating procedure competency and compliance with corrective action and preventive action.
  11. Demonstrate compounding calculations to increase accuracy and minimize medication error.
  12. Discover how to balance dosage form stability with the suitability of a compounded medication for a patient.
  13. Apply the concept of customization with appropriate compromise to a compounded medication.
  14. Relate dosage form design to bioavailability optimization, patient safety and a positive therapeutic outcome.
  15. Summarize the importance of the steps of a prescription assessment for compounding.
  16. Explain the importance of clinical decision-making processes in compounding.

Pharmacy Technicians

  1. Assess, write and construct marketing messages and material.
  2. Practice delivering a unique marketing message through verbal communication.
  3. Describe a two-year financial spreadsheet for a non-hazardous and hazardous compounding practice.
  4. Compute acquisition costs and establish the selling price of compounded medications.
  5. Summarize regulatory guidelines and standards of practice for compounding.
  6. Demonstrate how to customize standard operating procedures.
  7. Apply standards of practice for non-hazardous and hazardous drug compounding.
  8. Explain a collaborative compounding practice.
  9. Relate standards of practice and workflow dynamics to facility design models.
  10. Relate standard operating procedure competency and compliance with corrective action and preventive action.
  11. Solve compounding calculations to increase accuracy and minimize medication error.
  12. Demonstrate the importance of dosage form stability with the suitability of a compounded medication for a patient.
  13. Explain the concept of customization with appropriate compromise as it applies to a compounded medication.
  14. Describe dosage form design as it relates to bioavailability optimization, patient safety and a positive therapeutic outcome.
  15. Recognize the importance of the steps of a prescription assessment for compounding.
  16. Recognize the importance of clinical decision-making processes in compounding.

 

Hardware/software requirements

We will be using Zoom for this Virtual Seminar. We recommend joining from a desktop or laptop computer - full system requirements can be found here. You can download the Zoom client here.

If you will be joining from a tablet or mobile device, check out the system requirements here. More information: Getting started on Android and iOS.

Web browser
  • Windows: Internet Explorer 11+, Edge 12+, Firefox 27+, Chrome 30+
  • macOS: Safari 7+, Firefox 27+, Chrome 30+
  • Linux: Firefox 27+, Chrome 30+

Internet connection

  • ~600kbps (down) for high-quality video
  • ~1.2-1.8Mbps (down) for 720p HD video 
  • ~2-3Mbps (down) for 1080p HD video

Misc

  • Speakers/Microphone – built-in, USB plug-in, or wireless Bluetooth

Hardware

 MinimumRecommended
ProcessorSingle-core 1Ghz or higherDual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent)
RAMN/A4 GB

Testimonials

"The greatest aspect of the training that LP3 Network offers is the instructors that teach these courses. At my Non-sterile training, I was excited to have Mark Filosi as the main instructor. Mark is a self-made, well-established compounder that has the experience and skills needed to run his own compounding pharmacy, which he has been doing for years. Together, with the other facilitators, they make up a team that is at the forefront of compounding, teaching you how to compound beyond regulation standards.”

Kyle Dolan | Pharmacist, Missouri

 

“From my initial contact with the LP3 Network staff, to getting signed up, to the accommodations, to the actual quality of the course, everything was top notch. The information was presented in a non-biased way and there was a good balance of lecture and hands-on lab work when paired with the lab training. The training supports development as a compounder, giving you not only the information you need to compound, but the standard you should strive to uphold. One of the best aspects of the course was how supportive the instructors were. The lecturers make the course fun, interesting and do a great job making difficult topics enjoyable. The material is presented in such a way as to make the theoretical information usable in everyday practice. I feel compounding is the future of pharmacy and this course does a wonderful job at introducing the topic. It is also a great place to network and meet people from all over with different background. I will definitely take more courses in the future with LP3 Network.” 

Cathleen Gerhardt | Pharmacist

 

“This program was very straight to the point. I feel that it gave me the confidence and knowledge necessary to start marketing my compounding business. Everyone involved in the course was very patient and friendly. No matter how good you are, the instructors can still add to what you already know. I strongly recommend it.”

Kyro Nagib | Pharmacist, South Carolina


Promotional Video


FINANCIAL SUPPORT

This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.


COPYRIGHT

This CE Activity is Copyright © 2002-2024 LP3 Network.

Course summary
Available credit: 
  • 3.60 CEU (ACPE)
  • 36.00 Contact Hours
Event starts: 
01/13/2024 - 10:00am
Event ends: 
01/14/2024 - 5:00pm
Price:
$1395.00

Note: Facilitators are subject to change.

MARK FILOSI, BS Pharm, RPh
Contributor / Facilitator, LP3 Network
Consultant, Medisca Network
Compounding Pharmacist and Co-Founder, Family Care Pharmacy
Disclosure: None

Mr. Filosi is the owner of a thriving non-sterile compounding practice in Plant City, Florida, where he is responsible for the sales and marketing of the compounding segment of his business. Mr. Filosi has over 25 years of experience in both non-sterile and sterile compounding and is a former surveyor for the Pharmacy Compounding Accreditation Board (PCAB), a service of the Accreditation Commission for Health Care (ACHC).

Mr. Filosi graduated cum laude from Fitchburg State College in Fitchburg, Massachusetts, and then went on to graduate cum laude in Pharmacy from Massachusetts College of Pharmacy in Boston, Massachusetts. Today, Mr. Filosi is a preceptor for Florida A & M University, University of Florida, Virginia Commonwealth University, and Massachusetts College of Pharmacy.

In his free time, Mr. Filosi enjoys horseback riding with his daughter and being a scoutmaster for his son’s troop.

DAVID MASTROPIETRO, PhD, RPh
Contributor / Facilitator, LP3 Network
Assistant Professor, Department of Pharmaceutical Sciences, Nova Southeastern University College of Pharmacy
Consultant, Solara Labs
Disclosure: Consultant, Solara Labs

Dr. David Mastropietro is an Assistant Professor of Pharmaceutical Sciences at Nova Southeastern University, College of Pharmacy where he teaches the art of pharmacy compounding and the science of formulation development using classroom and laboratory methodologies. Dr. Mastropietro is also a pharmacist with over 20 years of experience practicing in community and hospital settings. He has 8 years’ experience consulting in the development, testing, and manufacturing of dietary supplements, serving as Senior Advisor for Formulation Development & Product Commercialization for Solara Labs, Inc. and Director of Personalized Formulation & Experience for Clean Living & Wellness. In addition to his teaching, pharmacist, and advisory roles, Dr. Mastropietro is active in research with 24 journal publications, over 85 abstracts and presentations, 3 book chapters, and 7 US & World patent applications.


Editor

NEIL COHEN, BSc
CE Program Developer
Disclosure: None

Contributors

JENNIFER CLARE, BSc
Contributor / Facilitator, LP3 Network
Senior Technical Support Service Representative, Medisca Network
Disclosure: None
 
MINDY CORMIER, Pharm D, RPh
Contributor / Facilitator, LP3 Network
Advanced Clinical & Formulation Pharmacist, Medisca Network
Disclosure: None
MARK FILOSI, BS Pharm, RPh
Contributor / Facilitator, LP3 Network
Consultant, Medisca Network
Compounding Pharmacist and Co-Founder, Family Care Pharmacy
Disclosure: None

DAVID MASTROPIETRO, PhD, RPh
Contributor / Facilitator, LP3 Network
Assistant Professor, Department of Pharmaceutical Sciences, Nova Southeastern University College of Pharmacy
Consultant, Solara Labs
Disclosure: Consultant, Solara Labs

PHARMACISTS & PHARMACY TECHNICIANS

The Home Study & Virtual Seminar are accredited for Pharmacists and Pharmacy Technicians by the Accreditation Council for Pharmacy Education (ACPE) through CPE Consultants, LLC.

Total CPE Credits: 36 CPE Hours = 3.6 CEUs

FormatHome StudyVirtual Seminar
TypeKnowledge-basedApplication-based
UAN0864-9999-21-015-H07-P/T0864-9999-21-041-L07-P/T
Credits24 CPE Hours = 2.4 CEUs12 CPE Hours = 1.2 CEUs
Release DateJuly 1, 2021August 29, 2021
Expiration DateJuly 1, 2024August 29, 2024


COMPLETION REQUIREMENTS

  1. Complete the pre-requisite Knowledge-based Home Study and associated learning assessment (minimum 80% passing grade, two attempts permitted).
  2. Participate in the Virtual Seminar and demonstrate participation in its interactive sessions.
  3. Complete a post-seminar learning assessment (minimum 80% passing grade, two attempts permitted).
  4. Submit a completed seminar activity evaluation online.

When the aforementioned steps have been completed and approved:

  • Pharmacists and Pharmacy Technicians registered in the United States will obtain a statement of completed credits on their NABP e-Profile within 60 days.
  • Pharmacists and Pharmacy Technicians registered elsewhere will receive an automated email from LP3 Network advising that they can download a statement of participation.
  • All participants will receive an automated email from LP3 Network advising that they can download the LP3 Network certificate of completion.
accreditorCPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

International participants should verify with their respective governing board for accreditation equivalency.


CANCELLATION AND REFUND POLICY

In the event that LP3 Network cancels a course, LP3 Network's sole liability shall be course repayment. In no event shall LP3 Network be responsible for any costs related to travel and/or accommodation. A written request must be sent to LP3 Network Inc. requesting ‘Cancellation without Transfer’ to an alternate live activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. There are no refunds, returns, or transfer requests upon purchase of a home study, digital work book, webinar, and eLearning modules. LP3 NETWORK INC. shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to LP3 NETWORK INC. in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, LP3 NETWORK INC. will not issue any refunds, only transfer to an alternate live activity event date.


TRANSFER POLICY

The transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity date. Failure to submit the “Transfer Request” at least 14 days prior to the original live activity date will default to the “Cancellation and Refund Policy”. The transfer policy can only be applied one (1) time. Transfer to a new live activity date must be within the current calendar year. Failure to attend the new live activity will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to approval by LP3 Network based on the number of available seats within the selected live activity. There are no refunds, returns, or transfers upon purchase of the home study.


HOME STUDY VERSION

Please note: Canadian participants will automatically receive access to the Canadian version of the Home Study. All other participants will automatically receive access to the US version of the Home Study. If you would like to switch versions, please contact us.

Price

Price:
$1395.00
Please login to Enroll or Add to Waitlist
Course expires: 
12/31/2025